Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Revascularization | 5 | 2023 | 249 | 2.190 |
Why?
|
| Vertebrobasilar Insufficiency | 4 | 2020 | 112 | 2.010 |
Why?
|
| Intracranial Arteriovenous Malformations | 4 | 2020 | 367 | 1.440 |
Why?
|
| Cerebral Angiography | 10 | 2020 | 1274 | 1.240 |
Why?
|
| Thrombectomy | 4 | 2017 | 708 | 1.230 |
Why?
|
| Moyamoya Disease | 2 | 2023 | 255 | 1.080 |
Why?
|
| Hemodynamics | 7 | 2021 | 4174 | 0.990 |
Why?
|
| Embolization, Therapeutic | 9 | 2021 | 1413 | 0.990 |
Why?
|
| Enbucrilate | 2 | 2020 | 30 | 0.870 |
Why?
|
| Carotid Artery Diseases | 2 | 2021 | 883 | 0.830 |
Why?
|
| Ischemic Attack, Transient | 2 | 2020 | 901 | 0.800 |
Why?
|
| Intracranial Aneurysm | 10 | 2021 | 1276 | 0.800 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 2733 | 0.720 |
Why?
|
| Middle Cerebral Artery | 3 | 2021 | 276 | 0.710 |
Why?
|
| Arteriovenous Fistula | 2 | 2020 | 314 | 0.690 |
Why?
|
| Stroke | 7 | 2021 | 9962 | 0.680 |
Why?
|
| Vertebral Artery | 2 | 2017 | 185 | 0.650 |
Why?
|
| Perfusion Imaging | 1 | 2020 | 196 | 0.650 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2020 | 1431 | 0.600 |
Why?
|
| Glioblastoma | 5 | 2019 | 3484 | 0.540 |
Why?
|
| Endovascular Procedures | 7 | 2020 | 2165 | 0.530 |
Why?
|
| Basilar Artery | 1 | 2017 | 205 | 0.520 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2018 | 1032 | 0.480 |
Why?
|
| Hyponatremia | 1 | 2016 | 279 | 0.450 |
Why?
|
| Stents | 5 | 2021 | 3314 | 0.430 |
Why?
|
| Carotid Artery, Internal | 4 | 2021 | 438 | 0.380 |
Why?
|
| Neurosurgical Procedures | 4 | 2020 | 2056 | 0.370 |
Why?
|
| STAT3 Transcription Factor | 2 | 2012 | 877 | 0.370 |
Why?
|
| Aneurysm, Ruptured | 3 | 2020 | 460 | 0.360 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2012 | 140 | 0.350 |
Why?
|
| Motor Cortex | 1 | 2017 | 995 | 0.340 |
Why?
|
| HIV Protease Inhibitors | 1 | 2011 | 432 | 0.310 |
Why?
|
| Chemokines | 1 | 2012 | 962 | 0.310 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 8986 | 0.300 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 422 | 0.300 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 795 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2023 | 36290 | 0.280 |
Why?
|
| Down Syndrome | 1 | 2015 | 892 | 0.280 |
Why?
|
| Antigens, Neoplasm | 2 | 2013 | 1998 | 0.280 |
Why?
|
| Microglia | 1 | 2015 | 1351 | 0.270 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 1475 | 0.270 |
Why?
|
| Brain Ischemia | 2 | 2017 | 3127 | 0.260 |
Why?
|
| Radiosurgery | 2 | 2013 | 1343 | 0.250 |
Why?
|
| Meningioma | 3 | 2019 | 1221 | 0.250 |
Why?
|
| Meningeal Neoplasms | 3 | 2019 | 1249 | 0.240 |
Why?
|
| Atherosclerosis | 1 | 2021 | 3517 | 0.240 |
Why?
|
| Trephining | 1 | 2023 | 13 | 0.220 |
Why?
|
| Cancer Vaccines | 1 | 2011 | 1046 | 0.220 |
Why?
|
| Rhizotomy | 2 | 2012 | 30 | 0.210 |
Why?
|
| Preoperative Care | 4 | 2019 | 2256 | 0.200 |
Why?
|
| Temporal Arteries | 2 | 2021 | 148 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2015 | 3075 | 0.200 |
Why?
|
| Dendritic Cells | 2 | 2012 | 2725 | 0.200 |
Why?
|
| Trigeminal Neuralgia | 2 | 2012 | 106 | 0.190 |
Why?
|
| Glycerol | 2 | 2012 | 276 | 0.190 |
Why?
|
| Polyvinyls | 2 | 2018 | 154 | 0.180 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2018 | 252 | 0.180 |
Why?
|
| Humans | 49 | 2023 | 760621 | 0.170 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2020 | 137 | 0.170 |
Why?
|
| Hydrodynamics | 1 | 2020 | 167 | 0.170 |
Why?
|
| Peptides | 1 | 2011 | 4354 | 0.160 |
Why?
|
| Immunotherapy | 2 | 2013 | 4642 | 0.160 |
Why?
|
| Cytokines | 2 | 2012 | 7343 | 0.150 |
Why?
|
| Neuronavigation | 1 | 2019 | 164 | 0.150 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2017 | 44 | 0.140 |
Why?
|
| Myxoma | 1 | 2017 | 114 | 0.140 |
Why?
|
| Treatment Outcome | 14 | 2021 | 65017 | 0.140 |
Why?
|
| Embolectomy | 1 | 2017 | 129 | 0.140 |
Why?
|
| Intubation | 1 | 2017 | 139 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 983 | 0.140 |
Why?
|
| Renal Artery Obstruction | 1 | 2017 | 224 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2020 | 1377 | 0.130 |
Why?
|
| Brain Stem Infarctions | 1 | 2016 | 31 | 0.130 |
Why?
|
| Vasospasm, Intracranial | 1 | 2018 | 215 | 0.130 |
Why?
|
| Vertebral Artery Dissection | 1 | 2016 | 51 | 0.130 |
Why?
|
| Aged | 17 | 2020 | 169152 | 0.130 |
Why?
|
| Male | 26 | 2020 | 359744 | 0.130 |
Why?
|
| Renal Artery | 1 | 2017 | 370 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 656 | 0.130 |
Why?
|
| Retrospective Studies | 15 | 2021 | 80372 | 0.130 |
Why?
|
| Microsurgery | 2 | 2020 | 796 | 0.130 |
Why?
|
| Middle Aged | 21 | 2021 | 220352 | 0.120 |
Why?
|
| Morbidity | 1 | 2020 | 1765 | 0.120 |
Why?
|
| Spinal Nerves | 1 | 2015 | 91 | 0.120 |
Why?
|
| Pia Mater | 1 | 2015 | 87 | 0.120 |
Why?
|
| Catheters | 1 | 2018 | 425 | 0.120 |
Why?
|
| Skull Base Neoplasms | 1 | 2018 | 269 | 0.120 |
Why?
|
| Brain Infarction | 1 | 2016 | 292 | 0.120 |
Why?
|
| Surgical Instruments | 1 | 2017 | 385 | 0.120 |
Why?
|
| Embolism | 1 | 2017 | 408 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 360 | 0.120 |
Why?
|
| Carotid Stenosis | 1 | 2021 | 878 | 0.110 |
Why?
|
| Female | 28 | 2020 | 391270 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1206 | 0.110 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 37 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 295 | 0.100 |
Why?
|
| Electrocoagulation | 1 | 2012 | 152 | 0.100 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 165 | 0.100 |
Why?
|
| Glioma | 2 | 2019 | 3420 | 0.100 |
Why?
|
| Nelfinavir | 1 | 2011 | 68 | 0.100 |
Why?
|
| Third Ventricle | 1 | 2011 | 74 | 0.090 |
Why?
|
| Fever | 1 | 2018 | 1617 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 464 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2017 | 938 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 2 | 2018 | 844 | 0.090 |
Why?
|
| Craniotomy | 1 | 2015 | 741 | 0.090 |
Why?
|
| Ventriculostomy | 1 | 2011 | 131 | 0.090 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2011 | 345 | 0.080 |
Why?
|
| Operating Rooms | 1 | 2016 | 789 | 0.080 |
Why?
|
| Medical Records | 1 | 2015 | 1407 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2021 | 54303 | 0.080 |
Why?
|
| Time Factors | 4 | 2020 | 40165 | 0.080 |
Why?
|
| Adult | 13 | 2020 | 219994 | 0.080 |
Why?
|
| Ischemia | 1 | 2017 | 1893 | 0.080 |
Why?
|
| Young Adult | 6 | 2018 | 58741 | 0.070 |
Why?
|
| Headache | 1 | 2015 | 1249 | 0.070 |
Why?
|
| Smoking | 3 | 2020 | 9073 | 0.070 |
Why?
|
| Risk Factors | 5 | 2021 | 74359 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2016 | 1446 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39261 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3442 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15289 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4573 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 18416 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4373 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2012 | 5039 | 0.060 |
Why?
|
| Hydrocephalus | 1 | 2011 | 763 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 6131 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2209 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2020 | 4048 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2007 | 859 | 0.060 |
Why?
|
| HIV Infections | 1 | 2011 | 17165 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2007 | 638 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2011 | 1183 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2011 | 1313 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5761 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 8552 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29658 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2017 | 6568 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2018 | 956 | 0.050 |
Why?
|
| Seizures | 1 | 2015 | 2917 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9280 | 0.050 |
Why?
|
| Neoplasms | 1 | 2011 | 22072 | 0.050 |
Why?
|
| Carotid Artery, External | 1 | 2021 | 38 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.050 |
Why?
|
| Solvents | 2 | 2012 | 292 | 0.050 |
Why?
|
| Adenoma | 1 | 2011 | 2148 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2007 | 1229 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58995 | 0.040 |
Why?
|
| Acute Disease | 1 | 2011 | 7269 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2020 | 41335 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2019 | 12103 | 0.040 |
Why?
|
| Patient Selection | 1 | 2012 | 4283 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2019 | 3607 | 0.040 |
Why?
|
| Child | 3 | 2018 | 79806 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2012 | 2758 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 24123 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 16939 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 3204 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 264 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12766 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2015 | 15697 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2017 | 130 | 0.040 |
Why?
|
| Pain | 1 | 2012 | 5066 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 334 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 2882 | 0.030 |
Why?
|
| Scalp | 1 | 2018 | 389 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 1666 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4024 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2012 | 23376 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1605 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 782 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 3584 | 0.030 |
Why?
|
| Brain | 2 | 2017 | 26951 | 0.030 |
Why?
|
| Infant | 1 | 2015 | 36060 | 0.030 |
Why?
|
| Catheterization | 1 | 2018 | 1432 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2015 | 42063 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2016 | 948 | 0.020 |
Why?
|
| United States | 1 | 2020 | 72461 | 0.020 |
Why?
|
| Gadolinium | 1 | 2017 | 959 | 0.020 |
Why?
|
| Maryland | 1 | 2012 | 275 | 0.020 |
Why?
|
| Facial Pain | 1 | 2012 | 120 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2011 | 103 | 0.020 |
Why?
|
| Reoperation | 2 | 2012 | 4291 | 0.020 |
Why?
|
| Comorbidity | 2 | 2019 | 10551 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2016 | 814 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 87810 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1440 | 0.020 |
Why?
|
| Prevalence | 2 | 2020 | 15687 | 0.020 |
Why?
|
| Hypertension | 2 | 2020 | 8594 | 0.020 |
Why?
|
| Prolactin | 1 | 2011 | 621 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 731 | 0.020 |
Why?
|
| Neck | 1 | 2013 | 731 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5785 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 663 | 0.020 |
Why?
|
| Tumor Escape | 1 | 2010 | 370 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5206 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 272 | 0.020 |
Why?
|
| Spleen | 1 | 2013 | 2298 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5305 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 1229 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2421 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 4193 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3758 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12531 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 1765 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2021 | 8525 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2012 | 1548 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7593 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 22023 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2007 | 897 | 0.020 |
Why?
|
| Lentivirus | 1 | 2007 | 506 | 0.020 |
Why?
|
| Animals | 5 | 2019 | 167963 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14660 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2471 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8515 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2934 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2007 | 1516 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1199 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2448 | 0.010 |
Why?
|
| Plasmids | 1 | 2007 | 2275 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2011 | 2058 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5781 | 0.010 |
Why?
|
| Leukocytes | 1 | 2010 | 2026 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2864 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6544 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2012 | 3528 | 0.010 |
Why?
|
| Mice | 3 | 2014 | 81208 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4353 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5797 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22053 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2013 | 3486 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8950 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5889 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4550 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8482 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10182 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12626 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2825 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5870 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 8313 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13451 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 13981 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 9501 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17624 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 15620 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23711 | 0.010 |
Why?
|
Concepts
(248)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_